Imported acquired immunodeficiency syndrome-related histoplasmosis in metropolitan France: A comparison of pre-highly active anti-retroviral therapy and highly active anti-retroviral therapy eras

American Journal of Tropical Medicine and Hygiene

Volumn 85, Issue 5, 2011, Pages 934-941

  Peigne, Vincent ^a,b   Dromer, Françoise ^c   Elie, Caroline ^d   Lidove, Olivier ^e   Lortholary, Olivier ^a,f   Chouaki, T ^g   Samad, Y ^g   Gaillat, J ^h   Leturdu, F ⁱ   Touahri, M ⁱ   Delassus, X ^j   Bouchaud, O ^k   Bentata, M ^k   Bouges Michel, C ^k   Poilane, Isabelle ^l   Fain, O ^l   Couprie, B ^m   Dutronc, H ⁿ   Rouveix, E ^o   Dunan, J ^o   Bretagne, S ^p   Sobel, A ^p   Levy Y ^p   Garrait, V ^q   Fauchet, N ^q   Deliu, F ^r   Lambotte, O ^s   De Lavaissiere, M ^s   Bourree P ^s   Jabot, J ^s   Piens, M A ^t   De Montbrison, F ^t   Bienvenu, A L ^t   Togent, E ^t   Ponseau, B ^t   Boibieu, A ^t   Perronne, V ⁱ   Eloy, O ⁱ   Genot, S ^u   Ranque, S ^u   Lepape, Y ^v   Dellamonica, P ^w   Roger, P M ^w   Gari Toussaint, M ^w   Lechiche, C ^x   Lachaud, L ^x   Hocqueloux, L ^y   Prazuk, T ^y   Poisson, D ^z   Houzet, S ^e   Chochillon, C ^e   Leport, C ^e   Matheron, S ^e   Wolff, M ^e   Choudat, L ^e   Rousseau, A ^e   Salmon, D ^aa   Blanche, P ^aa   Dupin, N ^aa   Franck, N ^aa   Baixench, M T ^aa   Poirot, J L ^ab   Meyohas, M C ^ab   Bollens, D ^ab   Jaureguiberry, S ^ac   Develoux, M ^ac   Dannaoui, E ^b   Karmochkine, M ^b   Aslangul, E ^ad   Cornet, M ^ad   Delcey, V ^ae   Viard, J P ^d   Dupont, B ^d   Lanternier, F ^d   Bougnoux, M E ^d   Datry, A ^af   Rozenbaum, W ^ag   Trylezinski, A ^ag   Molina, J M ^ah   Lacroix, C ^ah   Azoulay, E ^ah   Kauffman Lacroix, C ^ai   Godet, C ^aj   Arvieux, C ^ak   Chevrier, S ^ak   Favennec, L ^al   Tamion, F ^am   Lucht, P ^an   Imbert, P ^ao   Porte, L ^ap   Linas, M D ^ap   Benaoudia, F ^aq   more..

^a INSTITUT PASTEUR   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c Centre National de Référence Mycologie et Antifongiques   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e BICHAT HOSPITAL   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g AMIENS UNIVERSITY HOSPITAL   (France)

^h Maladies Infectieuses et Tropicales   (France)

ⁱ Maladies Infectieuses et Tropicales ^*  (France)

^j Centre Hospitalier Robert Ballanger CHRB   (France)

^k AVICENNE HOSPITAL   (France)

^l HÔPITAL JEAN VERDIER   (France)

^m Mycologie   (France)

ⁿ Maladies Infectieuses et Tropicales   (France)

^o HÔPITAL AMBROISE PARÉ   (France)

^p HENRI MONDOR HOSPITAL   (France)

^q CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^r Médecine Interne   (France)

^s BICÊTRE HOSPITAL   (France)

^t HOSPICES CIVILS DE LYON   (France)

^u ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^v Mycologie   (France)

^w UNIVERSITY HOSPITAL OF NICE   (France)

^x NÎMES UNIVERSITY HOSPITAL   (France)

^y Maladies Infectieuses et Tropicales   (France)

^z UFR Med Antilles Guyane Ctr H   (France)

^aa Hôpital Lariboisière ^*  (France)

^ab HÔPITAL SAINT ANTOINE   (France)

^ac HÔPITAL TENON   (France)

^ad HÔTEL DIEU   (France)

^ae HÔPITAL LARIBOISIÈRE   (France)

^af PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^ag HÔPITAL ROTHSCHILD   (France)

^ah SAINT LOUIS HOSPITAL   (France)

^ai Mycologie   (France)

^aj Maladies Infectieuses et Tropicales   (France)

^ak PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^al Mycologie   (France)

^am Réanimation Médicale   (France)

^an Maladies Infectieuses et Tropicales   (France)

^ao SERVICE D ENDOCRINOLOGIE   (France)

^ap CHU PURPAN   (France)

^aq Mycologie   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; FLUCONAZOLE; ITRACONAZOLE; VORICONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FRANCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPOALBUMINEMIA; HYPOXEMIA; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PROGNOSIS; RETROSPECTIVE STUDY; SYMPTOM; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIFUNGAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; FRANCE; HISTOPLASMOSIS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

HISTOPLASMA CAPSULATUM VAR. CAPSULATUM;

EID: 81155150450     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2011.11-0224     Document Type: Article

References (27)

1. Leads from the MMWR. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. JAMA 258: 1143-1145, 1149, 1153-1154.
2. Wheat LJ, 2006. Histoplasmosis: a review for clinicians from nonendemic areas. Mycoses 49: 274-282. (Pubitemid 43894049)
3. Wheat LJ, Connolly-Stringfield PA, Baker RL, Curfman MF, Eads ME, Israel KS, Norris SA, Webb DH, Zeckel ML, 1990. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 69: 361-374. (Pubitemid 20386532)
4. Segura L, Rojas M, Pelaez N, Shor-Posner G, RosaRe D, Moreno J, Klaskala W, Baum MK, 1997. Disseminated histoplasmosis and human immunodeficiency virus type 1 infection: risk factors in Guatemala. Clin Infect Dis 25: 343- 344.
5. Johnson PC, Wheat LJ, Cloud GA, Goldman M, Lancaster D, Bamberger DM, Powderly WG, Hafner R, Kauffman CA, Dismukes WE, 2002. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med 137: 105-109. (Pubitemid 34779154)
6. Wheat LJ, Freifeld AG, Kleiman MB, Baddley JW, McKinsey DS, Loyd JE, Kauffman CA, 2007. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 45: 807-825. (Pubitemid 47580372)
7. Wheat LJ, Chetchotisakd P, Williams B, Connolly P, Shutt K, Hajjeh R, 2000. Factors associated with severe manifestations of histoplasmosis in AIDS. Clin Infect Dis 30: 877-881. (Pubitemid 32250324)
8. de Francesco Daher E, de Sousa Barros FA, da Silva Junior GB, Takeda CF, Mota RM, Ferreira MT, Martins JC, Oliveira SA, Gutierrez-Adrianzen OA, 2006. Risk factors for death in acquired immunodeficiency syndrome-associated disseminated histoplasmosis. Am J Trop Med Hyg 74: 600-603. (Pubitemid 46774441)
9. Hajjeh RA, Pappas PG, Henderson H, Lancaster D, Bamberger DM, Skahan KJ, Phelan MA, Cloud G, Holloway M, Kauffman CA, Wheat LJ, 2001. Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virusinfected persons. Clin Infect Dis 32: 1215-1220. (Pubitemid 32381125)
10. Couppie P, Sobesky M, Aznar C, Bichat S, Clyti E, Bissuel F, El Guedj M, Alvarez F, Demar M, Louvel D, Pradinaud R, Carme B, 2004. Histoplasmosis and acquired immunodeficiency syndrome: a study of prognostic factors. Clin Infect Dis 38: 134-138. (Pubitemid 38045884)
11. Breton G, Adle-Biassette H, Therby A, Ramanoelina J, Choudat L, Bissuel F, Huerre M, Dromer F, Dupont B, Lortholary O, 2006. Immune reconstitution inflammatory syndrome in HIVinfected patients with disseminated histoplasmosis. AIDS 20: 119-121. (Pubitemid 41818123)
12. Antinori S, Magni C, Nebuloni M, Parravicini C, Corbellino M, Sollima S, Galimberti L, Ridolfo AL, Wheat LJ, 2006. Histoplasmosis among human immunodeficiency virus-infected people in Europe: report of 4 cases and review of the literature. Medicine (Baltimore) 85: 22-36. (Pubitemid 43884284)
13. Ashbee HR, Evans EG, Viviani MA, Dupont B, Chryssanthou E, Surmont I, Tomsikova A, Vachkov P, Enero B, Zala J, Tintelnot K, 2008. Histoplasmosis in Europe: report on an epidemiological survey from the European Confederation of Medical Mycology Working Group. Med Mycol 46: 57-65. (Pubitemid 351298242)
14. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Munoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE, 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46: 1813-1821.
15. French MA, Price P, Stone SF, 2004. Immune restoration disease after antiretroviral therapy. AIDS 18: 1615-1627. (Pubitemid 39095778)
16. Fine J, Gray R, 1999. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94: 496-509.
17. De Lavaissiere M, Manceron V, Bouree P, Garcon L, Bisaro F, Delfraissy JF, Lambotte O, Goujard C, 2009. Reconstitution inflammatory syndrome related to histoplasmosis, with a hemophago cytic syndrome in HIV infection. J Infect 58: 245-247.
18. Karimi K, Wheat LJ, Connolly P, Cloud G, Hajjeh R, Wheat E, Alves K, Lacaz Cd Cda S, Keath E, 2002. Differences in histoplasmosis in patients with acquired immunodeficiency syndrome in the United States and Brazil. J Infect Dis 186: 1655-1660. (Pubitemid 35379644)
19. Loulergue P, Bastides F, Baudouin V, Chandenier J, Mariani- Kurkdjian P, Dupont B, Viard JP, Dromer F, Lortholary O, 2007. Literature review and case histories of Histoplasma capsulatum var. duboisii infections in HIV-infected patients. Emerg Infect Dis 13: 1647-1652. (Pubitemid 350126190)
20. Baddley JW, Sankara IR, Rodriquez JM, Pappas PG, Many WJ Jr, 2008. Histoplasmosis in HIV-infected patients in a southern regional medical center: poor prognosis in the era of highly active antiretroviral therapy. Diagn Microbiol Infect Dis 62: 151-156.
21. Lortholary O, Poizat G, Zeller V, Neuville S, Boibieux A, Alvarez M, Dellamonica P, Botterel F, Dromer F, Chene G, 2006. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy. AIDS 20: 2183-2191. (Pubitemid 44684709)
22. Dheda K, Lampe FC, Johnson MA, Lipman MC, 2004. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy. J Infect Dis 190: 1670-1676. (Pubitemid 39411018)
23. Morris A, Wachter RM, Luce J, Turner J, Huang L, 2003. Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia. AIDS 17: 73-80. (Pubitemid 36106300)
24. Ledergerber B, Egger M, Erard V, Weber R, Hirschel B, Furrer H, Battegay M, Vernazza P, Bernasconi E, Opravil M, Kaufmann D, Sudre P, Francioli P, Telenti A, 1999. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA 282: 2220- 2226.
25. Lortholary O, Fontanet A, Memain N, Martin A, Sitbon K, Dromer F, 2005. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS 19: 1043-1049. (Pubitemid 40961144)
26. Breton G, Duval X, Estellat C, Poaletti X, Bonnet D, Mvondo Mvondo D, Longuet P, Leport C, Vilde JL, 2004. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin Infect Dis 39: 1709-1712. (Pubitemid 39578550)
27. Nacher M, Sarazin F, El Guedj M, Vaz T, Alvarez F, Nasser V, Randrianjohany A, Aznar C, Carme B, Couppie P, 2006. Increased incidence of disseminated histoplasmosis following highly active antiretroviral therapy initiation. J Acquir Immune Defic Syndr 41: 468-470.